Next |
home / stock / xers / xers message board
Subject | By | Source | When |
---|---|---|---|
Izzy Englander likes $XERS... | price_and_volume | investorshub | 05/27/2022 8:39:29 PM |
Anybody know what this is G85CVR010 ? It-showed-in-my-TD-acct-after | mess124 | investorshub | 01/20/2022 1:17:06 AM |
Yes indeed | Elgordo84 | investorshub | 12/31/2021 4:50:55 PM |
Nice catch in the low 2.00s. | alchemytrader | investorshub | 12/31/2021 1:22:50 PM |
Goodluck to all the Longs! | Elgordo84 | investorshub | 11/15/2021 2:41:48 PM |
Ramping up for sure. | $Money Bags$ | investorshub | 11/15/2021 2:33:41 PM |
I like what I see here! Looks like a | Elgordo84 | investorshub | 11/02/2021 3:01:51 AM |
PDUFA New Years ? | ahimsa27 | investorshub | 10/18/2021 5:10:46 PM |
They stalled the run when they first announced | $Money Bags$ | investorshub | 09/21/2021 12:44:08 PM |
Can we make it rain here? | ezyE | investorshub | 09/16/2021 1:24:25 AM |
Premarket action .. nice news. | kzivann | investorshub | 08/23/2021 12:30:33 PM |
Where is the bottom to$ XERS? I grabbed | tknuncle | investorshub | 08/13/2021 4:29:24 PM |
Item 5. | $Money Bags$ | investorshub | 07/12/2021 8:54:16 PM |
Blackrock sold 2.1m shares into it since their | $Money Bags$ | investorshub | 07/12/2021 8:51:25 PM |
Company on verge of bullish long run consolidated | Modlich | investorshub | 06/30/2021 12:06:43 AM |
Nom nom nom bring the gains. | $Money Bags$ | investorshub | 06/25/2021 6:56:04 PM |
They are acquiring another company, which pushed the | $Money Bags$ | investorshub | 06/04/2021 5:51:23 PM |
Recent announcement of deal caused PT to go | harr449 | investorshub | 06/04/2021 3:50:58 PM |
You guys enjoying the start of this nice run? | $Money Bags$ | investorshub | 06/04/2021 2:33:54 PM |
Delicious. | $Money Bags$ | investorshub | 06/03/2021 5:44:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Xeris Pharmaceuticals Inc. Company Name:
XERS Stock Symbol:
NASDAQ Market:
John Shannon, President and Chief Operating Officer, to succeed Paul Edick as new CEO and Board Director Transition timing aligns with the solid financial position of the Company, including consistently strong growth from its commercial franchise, healthy cash position, and the track reco...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that on July 1, 2024, the Compensation Committee of Xeris’ Boar...
In patients with Cushing’s syndrome maintained on Recorlev, a lower baseline mUFC was associated with higher cortisol normalization rate. Lower mUFC at baseline was also associated with lower maintenance dose requirements and lower rates of potentially clinically important liver-re...